title: Reply: To PMID 25841317.
authors.affiliation: Madurai, Tamilnadu, India.
authors.forename: Madhu
authors.initials: M
authors.lastname: Uddaraju
authors.affiliation: Madurai, Tamilnadu, India.
authors.forename: Jeena
authors.initials: J
authors.lastname: Mascarenhas
authors.affiliation: Madurai, Tamilnadu, India.
authors.forename: Mano Ranjan
authors.initials: MR
authors.lastname: Das
authors.affiliation: Madurai, Tamilnadu, India.
authors.forename: Naveen
authors.initials: N
authors.lastname: Radhakrishnan
authors.affiliation: Madurai, Tamilnadu, India.
authors.forename: Lalitha
authors.initials: L
authors.lastname: Prajna
authors.affiliation: Madurai, Tamilnadu, India.
authors.forename: Venkatesh N
authors.initials: VN
authors.lastname: Prajna
authors.affiliation: San Francisco, California.
authors.forename: Jeremy D
authors.initials: JD
authors.lastname: Keenan
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D003094:Collagen / Q000378:metabolism*; D003315:Cornea / Q000378:metabolism*; D003320:Corneal Ulcer / Q000188:drug therapy*; D003432:Cross-Linking Reagents; D015821:Eye Infections, Fungal / Q000188:drug therapy*; D005260:Female; D005658:Fungi / Q000302:isolation & purification*; D006801:Humans; D008297:Male
chemical_list: D000935:Antifungal Agents; D003432:Cross-Linking Reagents; D003094:Collagen